ProMetic's Lead Drug Candidate, PBI-4050, on Track to Enter Clinical Trial Program in September 2013

Marketwired
ProMetic's Lead Drug Candidate, PBI-4050, on Track to Enter Clinical Trial Program in September 2013
ProMetic Life Sciences Inc. Logo
View Comments (0)